IL91823A0 - Pharmaceutical preparation for treatment of thrombocytopenic or platelet function-deficient disease - Google Patents

Pharmaceutical preparation for treatment of thrombocytopenic or platelet function-deficient disease

Info

Publication number
IL91823A0
IL91823A0 IL91823A IL9182389A IL91823A0 IL 91823 A0 IL91823 A0 IL 91823A0 IL 91823 A IL91823 A IL 91823A IL 9182389 A IL9182389 A IL 9182389A IL 91823 A0 IL91823 A0 IL 91823A0
Authority
IL
Israel
Prior art keywords
thrombocytopenic
treatment
pharmaceutical preparation
platelet function
deficient disease
Prior art date
Application number
IL91823A
Other languages
English (en)
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of IL91823A0 publication Critical patent/IL91823A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL91823A 1988-10-07 1989-09-28 Pharmaceutical preparation for treatment of thrombocytopenic or platelet function-deficient disease IL91823A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP25198988 1988-10-07
JP1158089 1989-01-20
JP1744489 1989-01-30
JP3705689 1989-02-16
JP9195389 1989-04-13
JP12944789 1989-05-23

Publications (1)

Publication Number Publication Date
IL91823A0 true IL91823A0 (en) 1990-06-10

Family

ID=27548346

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91823A IL91823A0 (en) 1988-10-07 1989-09-28 Pharmaceutical preparation for treatment of thrombocytopenic or platelet function-deficient disease

Country Status (7)

Country Link
EP (1) EP0363083A3 (de)
JP (1) JPH0372429A (de)
KR (1) KR900005994A (de)
AU (1) AU620451B2 (de)
DK (1) DK496889A (de)
IL (1) IL91823A0 (de)
NZ (1) NZ230823A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348191B1 (en) 1986-07-08 2002-02-19 Genetics Institute, Inc. Production and use of IL-6
US6284237B1 (en) 1986-07-08 2001-09-04 Steven C. Clark Methods of treatment using IL-6
JPH04218000A (ja) * 1990-02-13 1992-08-07 Kirin Amgen Inc 修飾ポリペプチド
WO1993006840A1 (fr) * 1991-10-09 1993-04-15 Toray Industries, Inc. Medicament de prevention et de traitement de la tendance a l'hemorragie
WO1994000934A1 (en) * 1992-06-29 1994-01-06 Baxter Diagnostics Inc. High-speed time-multiplexed data transmission system
MX9304075A (es) * 1992-07-08 1994-04-29 Applied Research Systems Composicion farmaceutica para el tratamiento o profilaxis de los desordenes trombohemorragicos consuntivos.
JP3285663B2 (ja) * 1993-05-11 2002-05-27 ファナック株式会社 工具破損検出装置
US5822212A (en) * 1993-08-06 1998-10-13 Fanuc Ltd Machining load monitoring system
TW434021B (en) * 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable TPO-containing compositions
TW434020B (en) * 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions
KR100765455B1 (ko) * 2007-08-02 2007-10-12 (주)럭키기술단 누전 방지용 분전반
JP2017122049A (ja) * 2014-05-14 2017-07-13 国立大学法人 東京大学 インターロイキン１α（ＩＬ−１α）を含有する巨核球分化誘導及び血小板産生促進剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE220574T1 (de) * 1985-10-14 1987-11-26 Yeda Research And Development Co., Ltd., Rehovot Menschliches interferon-beta2a und interferon-beta2b
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
EP0257406B2 (de) * 1986-08-06 1998-08-12 Ajinomoto Co., Inc. Rekombinanter B-Zell-Differenzierungsfaktor

Also Published As

Publication number Publication date
DK496889D0 (da) 1989-10-06
EP0363083A2 (de) 1990-04-11
JPH0372429A (ja) 1991-03-27
AU4248489A (en) 1990-04-12
KR900005994A (ko) 1990-05-07
NZ230823A (en) 1992-04-28
AU620451B2 (en) 1992-02-20
DK496889A (da) 1990-04-08
EP0363083A3 (de) 1991-04-17

Similar Documents

Publication Publication Date Title
GR890100314A (en) Process for the preparation of drug absorbates
EP0363953A3 (en) Preparation of catheter
ZA895263B (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
EP0388434A4 (en) Differential delivery of therapeutic agents across the blood brain barrier
HU208256B (en) Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood
HU895444D0 (en) Process for the preparation of ophthalmic pharmaceutical composition
IL91823A0 (en) Pharmaceutical preparation for treatment of thrombocytopenic or platelet function-deficient disease
ZA889718B (en) Continuous process for the preparation of gelatin from powered bone and gelatin obtained
NZ223594A (en) Crystallised cephem-acid addition salt and pharmaceutical composition
ZA875847B (en) Pharmaceutical compositions for the treatment of occlusive vascular diseases
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
GB2205240B (en) N-imidazolyl derivatives of bicyclic compounds useful in medicine
EP0461225A4 (en) Circumvention of human tumor drug resistance
ZA897419B (en) Pharmaceutical preparation for treatment of thrombocytopenic or platelet function-deficient disease
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
HU905853D0 (en) Process for the preparation of medical products containing dopamine-autoreceptor-antagonists for treating drug dependence
AP8900157A0 (en) Pharmaceutical compositions for regeneration of leukocytes
IL89114A0 (en) Imidazol-2-yl-derivatives of bicyclic compounds,their preparation and pharmaceutical compositions containing them
PT87555A (pt) Process for the preparation and isolation of human splein and of pharmaceutical compounds containing it
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
HUT49483A (en) Process for producing pharmaceutical composition for inhibiting or diminishing harm of blood platelets
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
GB8829366D0 (en) Treatment of disease
NZ226462A (en) Preparation of artificial medicinal mud
GB8728989D0 (en) Medicinal preparation of physiological control of neuroendocrine system